Preparation and in vitro photodynamic activity of novel silicon(IV) phthalocyanines conjugated to serum albumins
Authors:
- Pui-Chi LoPui-Chi Lo
- Yan-Mei ChenYCYan-Mei Chen
- Janice C. LaiJLJanice C. Lai
- Wing-Ping FongWFWing-Ping Fong
- Dennis K.P. NgDennis K.P. Ng
- 1 May 2006
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 100 (5-6) , 946-951
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The present and future role of photodynamic therapy in cancer treatmentThe Lancet Oncology, 2004
- Current Clinical and Preclinical Photosensitizers for Use in Photodynamic TherapyJournal of Medicinal Chemistry, 2004
- Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME)International Journal of Pharmaceutics, 2004
- Photophysical properties of porphyrinoid sensitizers non-covalently bound to host molecules; models for photodynamic therapyCoordination Chemistry Reviews, 2004
- Targeted photodynamic therapy via receptor mediated delivery systemsAdvanced Drug Delivery Reviews, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- State of the art in the delivery of photosensitizers for photodynamic therapyJournal of Photochemistry and Photobiology B: Biology, 2002
- A Novel Macromolecular Prodrug Concept Exploiting Endogenous Serum Albumin as a Drug Carrier for Cancer ChemotherapyJournal of Medicinal Chemistry, 2000
- Metal Complexes as Photo- and RadiosensitizersChemical Reviews, 1999
- Far-red-absorbing photosensitizers: their use in the photodynamic therapy of tumoursJournal of Photochemistry and Photobiology A: Chemistry, 1992